| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.04 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.34 | 0.04 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |